Lipid II as a target for antibiotics

Nature Reviews. Drug Discovery
Eefjan Breukink, Ben de Kruijff

Abstract

Lipid II is a membrane-anchored cell-wall precursor that is essential for bacterial cell-wall biosynthesis. The effectiveness of targeting Lipid II as an antibacterial strategy is highlighted by the fact that it is the target for at least four different classes of antibiotic, including the clinically important glycopeptide antibiotic vancomycin. However, the growing problem of bacterial resistance to many current drugs, including vancomycin, has led to increasing interest in the therapeutic potential of other classes of compound that target Lipid II. Here, we review progress in understanding of the antibacterial activities of these compounds, which include lantibiotics, mannopeptimycins and ramoplanin, and consider factors that will be important in exploiting their potential as new treatments for bacterial infections.

References

Jun 1, 1992·The Journal of Antibiotics·J ShojiT Yoshida
Jun 1, 1992·The Journal of Antibiotics·S ChatterjeeG Seibert
Dec 1, 1991·Applied and Environmental Microbiology·K A StevensT R Klaenhammer
Jun 1, 1988·The Journal of Antibiotics·J ShojiE Kondo
Sep 1, 1973·Antimicrobial Agents and Chemotherapy·P E Linnett, J L Strominger
Aug 12, 1966·Biochemical and Biophysical Research Communications·A N Chatterjee, H R Perkins
Oct 1, 1980·Archives of Microbiology·P ReisingerW P Hammes
Aug 1, 1993·Antimicrobial Agents and Chemotherapy·M Arthur, P Courvalin
Mar 1, 1993·European Journal of Biochemistry·M J GarceráW N Konings
Aug 1, 1996·The Journal of Applied Bacteriology·E A DaviesM R Adams
Feb 1, 1996·Antonie van Leeuwenhoek·J Delves-BroughtonJ Hugenholtz
Sep 18, 1997·Applied and Environmental Microbiology·A VerheulT Abee
Jan 22, 1998·Applied and Environmental Microbiology·A D Crandall, T J Montville
Feb 4, 1998·Antimicrobial Agents and Chemotherapy·H BrötzH G Sahl
May 13, 1998·The Journal of Antimicrobial Chemotherapy·E SeverinaA Tomasz
Jun 12, 1998·Biochemistry·E BreukinkO P Kuipers
Sep 17, 1998·The Journal of Antimicrobial Chemotherapy·B P GoldsteinR Novick
Mar 3, 1999·The Journal of Antimicrobial Chemotherapy·S MaesakiS Kohno
Dec 22, 1999·Antimicrobial Agents and Chemotherapy·M Mota-MeiraM C Lavoie
Feb 7, 2001·Applied and Environmental Microbiology·H C Mantovani, J B Russell
May 29, 2002·Proceedings of the National Academy of Sciences of the United States of America·Predrag CudicDewey G McCafferty
Aug 15, 2002·Journal of the American Chemical Society·Haiyin HeGuy T Carter
Sep 3, 2002·Chemistry & Biology·Predrag CudicDewey G McCafferty

❮ Previous
Next ❯

Citations

May 23, 2008·Applied Microbiology and Biotechnology·Santosh Kumar Tiwari, Sheela Srivastava
Jul 21, 2010·Applied Microbiology and Biotechnology·Takeshi ZendoKenji Sonomoto
Sep 25, 2010·Applied Microbiology and Biotechnology·Stefano DonadioDaniela Jabes
Apr 25, 2012·Applied Microbiology and Biotechnology·Steven BoakesJesús Cortés
Mar 16, 2013·Journal of Industrial Microbiology & Biotechnology·Yanhong LiuLihan Huang
Aug 20, 2009·ACS Chemical Biology·Sumana Sanyal, Anant K Menon
Jun 12, 2010·Journal of the American Chemical Society·Alberto PlazaCarole A Bewley
Jan 28, 2012·Journal of the American Chemical Society·Avena C RossJohn C Vederas
Jun 8, 2010·Journal of Medicinal Chemistry·Jed F Fisher, Shahriar Mobashery
Jun 3, 2011·Journal of Medicinal Chemistry·Tucker C RobertsFloyd E Romesberg
Dec 16, 2006·The Journal of Organic Chemistry·Wilfred A van der Donk
May 19, 2011·The Journal of Antibiotics·Mark S Butler, Matthew A Cooper
Aug 1, 2009·Natural Product Reports·John A McIntoshEric W Schmidt
Aug 18, 2012·Molecular BioSystems·Haihong HaoZonghui Yuan
Aug 12, 2009·Proceedings of the National Academy of Sciences of the United States of America·James B HamburgerPatrick J Loll
Mar 21, 2012·Proceedings of the National Academy of Sciences of the United States of America·Neha GargWilfred A van der Donk
Jul 31, 2009·The Journal of Biological Chemistry·Gang WeiWuyuan Lu
Aug 21, 2012·The Journal of Biological Chemistry·Nina A ChristJens Wöhnert
May 12, 2009·Foodborne Pathogens and Disease·Jun Lin
Aug 29, 2009·Science·Michael A Fischbach, Christopher T Walsh
May 29, 2010·Science·Tanja SchneiderHans-Henrik Kristensen
Mar 19, 2008·Antimicrobial Agents and Chemotherapy·Hilário C Mantovani, James B Russell
Jun 13, 2012·Antimicrobial Agents and Chemotherapy·Aline Dias PaivaHilário Cuquetto Mantovani
Nov 17, 2010·Antimicrobial Agents and Chemotherapy·Anna StarońThorsten Mascher
Sep 24, 2008·Antimicrobial Agents and Chemotherapy·Ian M GutSteven R Blanke
Sep 12, 2012·Antimicrobial Agents and Chemotherapy·Diana WolfThorsten Mascher
Feb 2, 2011·Antimicrobial Agents and Chemotherapy·Fuminori YoneyamaKenji Sonomoto
Jul 18, 2012·Antimicrobial Agents and Chemotherapy·Lorraine A DraperR Paul Ross
Mar 11, 2009·Antimicrobial Agents and Chemotherapy·Zhizeng SunLiandong Huan
Mar 14, 2012·Antimicrobial Agents and Chemotherapy·Yang SongBrian J Wilkinson
Jun 10, 2008·Applied and Environmental Microbiology·Beatriz MartínezImke Wiedemann
Jun 30, 2009·Applied and Environmental Microbiology·Máire BegleyR Paul Ross
Sep 16, 2008·Applied and Environmental Microbiology·Anneke KuipersGert N Moll
Dec 31, 2008·Applied and Environmental Microbiology·Shawanda Wilson-StanfordLeif Smith
Feb 14, 2012·Applied and Environmental Microbiology·J P BitounZ T Wen
Jan 15, 2011·Clinical Microbiology Reviews·Lynn L Silver

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antimicrobial Resistance (ASM)

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Bacterial Cell Wall Structure (ASM)

Bacterial cell walls are made of peptidoglycan (also called murein), which is made from polysaccharide chains cross-linked by unusual peptides containing D-amino acids. Here is the latest research on bacterial cell wall structures.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Anti-Arrhythmic Drug Therapies

Anti-arrhythmic drugs are used to prevent abnormal heart rhythms. These medications are used in conditions including, ventricular tachycardia, ventricular fibrillation and atrial fibrillation. Discover the latest research on anti-arrhythmic drug therapies here.

Antimicrobial Resistance

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Bacterial Cell Wall Structure

Bacterial cell walls are made of peptidoglycan (also called murein), which is made from polysaccharide chains cross-linked by unusual peptides containing D-amino acids. Here is the latest research on bacterial cell wall structures.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.